SCHEMBL27768211

SCHEMBL27768211

CC(C)(C)C(=O)ON1CCC(c2nc(CCl)cs2)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.42
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 1/20 0.36
AOC3 Q16853 1/20 0.35
SLC6A3 Q01959 2/20 0.34
DNM1L O00429 2/20 0.33
F2RL3 Q96RI0 1/20 0.33
KDM4E B2RXH2 2/20 0.32
RAB9A P51151 2/20 0.32
ALDH1A1 P00352 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
FAAH O00519 1/20 0.32
SHMT1 P34896 1/20 0.32
TMIGD3 P0DMS9 1/20 0.32
ADORA1 P30542 1/20 0.32
NPC1 O15118 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28784616 0.93 GPR119 (0.39) GPR119SMN1; SMN2KMT2AAOC3SLC6A3
SCHEMBL27789573 0.89 SMN1; SMN2 (0.37) GPR119SMN1; SMN2KMT2AAOC3SLC6A3
SCHEMBL27873794 0.88 GPR119 (0.42) GPR119SMN1; SMN2AOC3SLC6A3DNM1L
SCHEMBL27768028 0.88 GPR119 (0.35) GPR119SMN1; SMN2KMT2AAOC3DNM1L
SCHEMBL27975186 0.82 KMT2A (0.41) GPR119SMN1; SMN2KMT2AAOC3SLC6A3
SCHEMBL907209 0.82 GPR119 (0.58) GPR119SMN1; SMN2KMT2AF2RL3KDM4E
SCHEMBL27768120 0.82 GPR119 (0.54) GPR119SMN1; SMN2KMT2ASLC6A3F2RL3
SCHEMBL27828645 0.81 GPR119 (0.35) GPR119RAB9AFAAHTMIGD3ADORA1
SCHEMBL28781307 0.80 GPR119 (0.54) GPR119SMN1; SMN2KMT2AF2RL3RAB9A
SCHEMBL27789523 0.80 SMN1; SMN2 (0.37) SMN1; SMN2KMT2AAOC3KDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101616586-B Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders CYMABAY THERAPEUTICS INC 2014-08-13 CN disclosed
CN-102026636-B Oxymethylene aryl compounds and uses thereof METABOLEX INC 2014-07-16 CN disclosed
CN-103037843-A Compositions of 5-ethyl-2- {4- [4- (4-tetrazol-1-yl-phenoxymethyl) -thiazol-2-yl ] -piperidin-1-yl } -pyrimidine METABOLEX INC 2013-04-10 CN disclosed
CN-102026636-A Oxymethylene aryl compounds and uses thereof METABOLEX INC 2011-04-20 CN disclosed
CN-101616586-A The heterocyclic receptor agonists of treatment diabetes and metabolic disorder METABOLEX INC 2009-12-30 CN disclosed